184 related articles for article (PubMed ID: 24792619)
21. Withaferin A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines.
Das T; Roy KS; Chakrabarti T; Mukhopadhyay S; Roychoudhury S
Biochem Pharmacol; 2014 Sep; 91(1):31-9. PubMed ID: 24995417
[TBL] [Abstract][Full Text] [Related]
22. The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
Santibáñez M; Gallardo D; Morales F; López A; Prada D; Mendoza J; Castro C; de León DC; Oñate LF; Perez D; Mohar A; Herrera LA
Pharmacogenet Genomics; 2013 Apr; 23(4):190-9. PubMed ID: 23407047
[TBL] [Abstract][Full Text] [Related]
23. Expression of the mitotic-arrest deficiency 2 is associated with chemotherapy resistance in ovarian serous adenocarcinoma.
Nakano Y; Sumi T; Teramae M; Morishita M; Fukuda T; Terada H; Yoshida H; Matsumoto Y; Yasui T; Ishiko O
Oncol Rep; 2012 Oct; 28(4):1200-4. PubMed ID: 22797604
[TBL] [Abstract][Full Text] [Related]
24. Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis.
Borges KS; Moreno DA; Martinelli CE; Antonini SR; de Castro M; Tucci S; Neder L; Ramalho LN; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2013 Nov; 60(11):1809-16. PubMed ID: 23788275
[TBL] [Abstract][Full Text] [Related]
25. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Stavnes HT; Holth A; Don T; Kærn J; Vaksman O; Reich R; Trope' CG; Davidson B
Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Mad2 and BubR1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis.
Wang L; Wang J; Jin Y; Zheng J; Yang Y; Xi X
J Obstet Gynaecol Res; 2019 Dec; 45(12):2407-2418. PubMed ID: 31523901
[TBL] [Abstract][Full Text] [Related]
27. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
28. Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer.
Bates M; Furlong F; Gallagher MF; Spillane CD; McCann A; O'Toole S; O'Leary JJ
Cancer Lett; 2020 Jan; 469():11-21. PubMed ID: 31593803
[TBL] [Abstract][Full Text] [Related]
29. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
30. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
Wang X; Jin DY; Ng RW; Feng H; Wong YC; Cheung AL; Tsao SW
Cancer Res; 2002 Mar; 62(6):1662-8. PubMed ID: 11912137
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
Elstrand MB; Stavnes HT; Tropé CG; Davidson B
Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883
[TBL] [Abstract][Full Text] [Related]
32. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
Bamias A; Bamia C; Zagouri F; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
Oncology; 2013; 84(3):158-65. PubMed ID: 23296063
[TBL] [Abstract][Full Text] [Related]
33. BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation.
Choi E; Park PG; Lee HO; Lee YK; Kang GH; Lee JW; Han W; Lee HC; Noh DY; Lekomtsev S; Lee H
Dev Cell; 2012 Feb; 22(2):295-308. PubMed ID: 22340495
[TBL] [Abstract][Full Text] [Related]
34. Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry.
Burum-Auensen E; De Angelis PM; Schjølberg AR; Kravik KL; Aure M; Clausen OP
J Histochem Cytochem; 2007 May; 55(5):477-86. PubMed ID: 17242465
[TBL] [Abstract][Full Text] [Related]
35. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of the spindle checkpoint protein BubR1 is associated with high cell proliferation in primary gastrointestinal diffuse large B cell lymphoma.
Chen F; Yang G; Xia B
Cell Biochem Biophys; 2013 Jul; 66(3):747-52. PubMed ID: 23400934
[TBL] [Abstract][Full Text] [Related]
37. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer.
Rimkus C; Friederichs J; Rosenberg R; Holzmann B; Siewert JR; Janssen KP
Int J Cancer; 2007 Jan; 120(1):207-11. PubMed ID: 17044027
[TBL] [Abstract][Full Text] [Related]
38. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
39. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
40. Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1.
Davenport J; Harris LD; Goorha R
Exp Cell Res; 2006 Jun; 312(10):1831-42. PubMed ID: 16600213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
